TWO · 4139.TWO
Ma Kuang Healthcare Holding Limited
NT$41.95-NT$1.55 (-3.56%)
Ma Kuang Healthcare Holding Limited’s quoted price sits in the upper half of its reported 52-week range, 7.8% below the high.
Loading market information…
TWO · 6847.TWO · TWD
Stock price
Quote as of Oct 30, 2026, 05:31 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
Puriblood Medical Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 23.48% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Puriblood Medical Co., Ltd., based in Hsinchu City, Taiwan, and established in 2016, specializes in manufacturing and distributing advanced solutions for blood component separation. The company's diverse product portfolio features filters designed for leukoreduction in various blood products, including red blood cells, platelets, and whole blood. They also provide immediate filtration systems for whole blood, alongside Devin blood fractionation membrane filters and Minipuri cell screening syringe filters. A key innovation from Puriblood Medical is its proprietary P-Tex Technology, which leverages a bio-inspired molecular design based on a zwitterionic copolymer structure.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$41.95-NT$1.55 (-3.56%)
Ma Kuang Healthcare Holding Limited’s quoted price sits in the upper half of its reported 52-week range, 7.8% below the high.
NT$27.15-NT$1.35 (-4.74%)
Prince Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 19.67% below the high.
NT$30.60-NT$0.05 (-0.16%)
Level Biotechnology Inc.’s quoted price sits in the lower half of its reported 52-week range, 11.82% below the high.
NT$15.40-NT$0.65 (-4.05%)
AmCad BioMed Corporation’s quoted price sits in the upper half of its reported 52-week range, 18.3% below the high.
NT$13.95-NT$0.05 (-0.36%)
LAUNXP Biomedical Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 45.19% below the high.
NT$24.00NT$0.00 (0.0%)
Wiltrom Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 20.66% below the high.
NT$31.20-NT$1.80 (-5.45%)
Ttbio Corp.’s quoted price sits in the lower half of its reported 52-week range, 48.17% below the high.
NT$12.85-NT$0.55 (-4.1%)
Kim Forest Enterprise Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 44.01% below the high.
